What are the key clinical features to consider when diagnosing Eosinophilic Granulomatosis with Polyangiitis (EGPA) in a patient presenting with respi

Guideline-aligned answer with reasoning, red flags and references. Clinically reviewed by Dr Kola Tytler MBBS CertHE MBA MRCGP.

Posted: 17 August 2025Updated: 17 August 2025 Guideline-Aligned (High Confidence) Clinically Reviewed
Dr Kola Tytler MBBS CertHE MBA MRCGPClinical Lead • iatroX

Key clinical features to consider when diagnosing Eosinophilic Granulomatosis with Polyangiitis (EGPA) in a patient presenting with respiratory symptoms include:

  • Asthma and allergic rhinitis: A history of adult-onset asthma, often severe and difficult to control, is a hallmark feature preceding other manifestations in EGPA .
  • Peripheral blood eosinophilia: Marked eosinophilia in peripheral blood is a critical diagnostic clue, reflecting eosinophilic inflammation characteristic of EGPA .
  • Respiratory symptoms: These include wheezing, cough, dyspnoea, and sometimes pulmonary infiltrates visible on imaging, which may mimic asthma exacerbations or eosinophilic pneumonia .
  • Systemic vasculitic features: Although respiratory symptoms predominate, clinicians should assess for signs of small to medium vessel vasculitis such as palpable purpura, mononeuritis multiplex, or constitutional symptoms, which support EGPA diagnosis .
  • Extravascular eosinophilic granulomas: Tissue biopsy, if performed, may reveal eosinophilic-rich granulomatous inflammation, aiding diagnosis .
  • ANCA status: Anti-neutrophil cytoplasmic antibodies (ANCA), particularly MPO-ANCA, may be positive in a subset of patients and can help differentiate EGPA from other eosinophilic lung diseases, though ANCA-negative cases are common .
  • Exclusion of mimics: Given overlapping features with COVID-19 and other eosinophilic lung diseases, careful clinical and laboratory evaluation is essential to avoid misdiagnosis .

In summary, the diagnosis of EGPA in patients with respiratory symptoms relies on recognizing adult-onset asthma with marked eosinophilia, systemic vasculitic signs, and supportive serology or histology, while excluding other causes of eosinophilic lung disease .

Educational content only. Always verify information and use clinical judgement.